Oncology Bulletin
Oncology Central
Oncology Central is a free online resource that unites all aspects of oncology to support.
What disparities exist in cancer screening and how does this impact patient outcomes? Listen to our latest podcast episode with Dr Kilan Ashad-Bishop from the American Cancer Society to find out.
LATEST ARTICLES
JOURNAL ARTICLES
Trastuzumab-anns is a biosimilar to trastuzumab, which is approved by the EMA and US FDA for treatment of HER2+ early and metastatic breast cancer. Read about its use in seven clinical oncology practices in the EU.
In this special edition of editor’s highlights, Michael Bell Managing Editor, looks at three articles published over the last 12 months in Future Oncology, concerning greater engagement and representation for Black, Indigenous and People of Colour (BIPOC) people in oncological research.
Find out details of a real-world database analysis exploring how adding palbociclib to an aromatase inhibitor could prolong the life of people with metastatic HR+/HER2– breast cancer in routine clinical practice.?
"Thrilled to embark on a journey of renewal and longevity with our team at Eternal Life! Each day is a chance to evolve and grow, embracing the endless possibilities ahead. ???" Comment: "Absolutely inspiring! ?? As Albert Einstein once said, 'Life is like riding a bicycle. To keep your balance, you must keep moving.' Keep embracing the journey, one step at a time. ??"